Children’s Hospital of PhiladelphiaWorld’s first personalised CRISPR therapy treats child with rare metabolic disorder
Researchers at Children’s Hospital of Philadelphia and Penn Medicine have successfully treated an infant with a rare genetic disease using a bespoke CRISPR gene editing therapy, marking a watershed moment in personalised genomic medicine.
